{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:42:52Z","timestamp":1760838172502,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bmc.2020.115892","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T18:30:09Z","timestamp":1606588209000},"page":"115892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents"],"prefix":"10.1016","volume":"29","author":[{"given":"Xiaoke","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueting","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115892_b0005","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejmech.2018.03.076","article-title":"An overview of quinazolines: pharmacological significance and recent developments","volume":"151","author":"Alagarsamy","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115892_b0010","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01800-19","article-title":"Osteopetrosis-associated transmembrane protein 1 recruits RNA exosome to restrict hepatitis B virus replication","volume":"94","author":"Ma","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2020.115892_b0015","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/ijc.30553","article-title":"HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K\/AKT signal pathway","volume":"140","author":"Zhu","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bmc.2020.115892_b0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2018.11.020","article-title":"HBV induces different responses of the hepatocytes and oval cells during HBV-related hepatic cirrhosis","volume":"443","author":"Zhang","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2020.115892_b0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2018.12.047","article-title":"5-Aminothiophene-2, 4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors","volume":"164","author":"Tang","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115892_b0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/fvl-2019-0133","article-title":"Strategies to eliminate HBV infection: an update","volume":"15","author":"Tang","year":"2020","journal-title":"Future Virol"},{"key":"10.1016\/j.bmc.2020.115892_b0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/acsinfecdis.7b00144","article-title":"Discovery of small molecule therapeutics for treatment of chronic HBV infection","volume":"4","author":"Feng","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2020.115892_b0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/cbdd.13512","article-title":"Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non-nucleoside hepatitis B virus inhibitors by exploring the solvent-exposed region","volume":"95","author":"Yu","year":"2020","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2020.115892_b0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/hep4.1480","article-title":"Chronic viral hepatitis: current management and future directions","volume":"4","author":"Do AReau","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.bmc.2020.115892_b0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejmech.2017.06.062","article-title":"Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector","volume":"138","author":"Sari","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115892_b0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejmech.2019.01.059","article-title":"Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors","volume":"166","author":"Pan","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115892_b0060","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1021\/op400119b","article-title":"Identification, synthesis, and strategy for minimization of potential impurities in the preclinical anti-HBV drug Y101","volume":"17","author":"Hu","year":"2013","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.bmc.2020.115892_b0065","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1007\/s11164-015-2169-0","article-title":"Process development of clinical anti-HBV drug Y101: identification and synthesis of novel impurities","volume":"42","author":"Hu","year":"2015","journal-title":"Res Chem Intermediat"},{"key":"10.1016\/j.bmc.2020.115892_b0070","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejmech.2017.12.042","article-title":"Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors","volume":"144","author":"Qiu","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115892_b0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2019.05.014","article-title":"Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors","volume":"176","author":"Qiu","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115892_b0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2014.04.002","article-title":"Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion","volume":"107","author":"Xu","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmc.2020.115892_b0085","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1128\/AAC.01558-15","article-title":"A novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation","volume":"59","author":"Wang","year":"2015","journal-title":"Antimicrob Agents Ch"},{"key":"10.1016\/j.bmc.2020.115892_b0090","doi-asserted-by":"crossref","first-page":"197677","DOI":"10.1016\/j.virusres.2019.197677","article-title":"Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly","volume":"271","author":"Toyama","year":"2019","journal-title":"Virus Res"},{"key":"10.1016\/j.bmc.2020.115892_b0095","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.1513803112","article-title":"High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein","volume":"112","author":"Klumpp","year":"2015","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2020.115892_b0100","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1021\/acs.jmedchem.6b00879","article-title":"Design and synthesis of orally bioavailable 4-methyl heteroaryldihydropyrimidine based hepatitis B virus (HBV) capsid inhibitors","volume":"59","author":"Qiu","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115892_b0105","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.510280432","article-title":"Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus","volume":"28","author":"Delaney WEIsom","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bmc.2020.115892_b0110","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/jm101325h","article-title":"Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis B virus through targeting host heat stress cognate 70","volume":"54","author":"Gao","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2020.115892_b0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00044-018-2270-1","article-title":"Identification of protein arginine methyltransferase 7 (PRMT7) inhibitor by virtual screening and biological evaluation in vitro","volume":"28","author":"Liu","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bmc.2020.115892_b0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00044-019-02479-2","article-title":"Discovery of small molecule sirt1 activator using high-throughput virtual screening, molecular dynamics simulation, molecular mechanics generalized born\/surface area (MM\/GBSA) calculation, and biological evaluation","volume":"29","author":"An","year":"2020","journal-title":"Med. Chem. Res."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620307227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620307227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:10:38Z","timestamp":1760836238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620307227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"alternative-id":["S0968089620307227"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115892","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115892"}}